LC-913 series

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameLC-913 series

Drug Alias Nameantileukemics (Leuchemix)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesLeuchemix

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesLeuchemix

Active IndicationsN/A

Inactive IndicationsHematologic Neoplasms

ATC CodeN/A